Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | MEDANTA Global Health Limited Pharma · Large | ASTERDM Aster DM Healthcare Limited Pharma · Small | NH Narayana Hrudayalaya Ltd. Pharma · Small | AGARWALEYE Dr. Agarwal's Health Care Limited Pharma · Micro |
|---|---|---|---|---|
| Final Score | 44 | 24 | 47 | 30 |
| Verdict | WATCHLIST | OVERVALUED | FAIR VALUE | OVERVALUED |
| Style | WATCHLIST | OVERVALUED | Financial Turnaround | OVERVALUED |
| Piotroski | 8/9 | 8/9 | 7/9 | 8/9 |
| Valuation | 0/30 | 0/30 | 0/30 | 0/30 |
| Growth | 17/25 | 11/25 | 21/25 | 14/25 |
| Quality | 10/20 | 2/20 | 10/20 | 0/20 |
| Balance Sheet | 8/15 | 3/15 | 7/15 | 6/15 |
| Cash Flow | 4/10 | 4/10 | 4/10 | 5/10 |
| Price | ₹1,242 | ₹792.5 | ₹1,934.3 | ₹445.55 |
| P/E | 58.40 | 97.30 | 46.10 | 108.00 |
| P/B | 8.23 | 8.67 | 8.65 | 7.07 |
| ROE | 15.20% | 10.70% | 20.90% | 6.81% |
| ROCE | 17.10% | 11.40% | 15.40% | 11.10% |
| Debt / Equity | 0.30 | 0.49 | 1.29 | 0.57 |
| FCF Yield | — | 0.93% | — | 1.47% |
| Dividend Y | 0.04% | 0.65% | 0.23% | — |
| Altman Z | 8.43 | 7.83 | 4.64 | 5.88 |
| Promoter % | 33.01% | 40.39% | 63.27% | 32.35% |
| Mkt Cap (₹Cr) | 32557.00 | 39717.00 | 39249.00 | 14334.00 |
| Graham # | ₹261.66 | ₹121.99 | ₹443.74 | ₹77.71 |
| Fair PE | 42.0 | 42.0 | 42.0 | 42.0 |
| MoS % | -42.9% | -151.9% | -16.8% | -152.6% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startMEDANTA116
ASTERDM180
NH150
AGARWALEYE112